Rik Olde Engberink

Dr. Rik Olde Engberink

orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2015 in Hypertension
Verified
Journal Article
Open access
PDF file
RERik Olde Engberink
Rik Olde Engberink
WFWijnanda J. Frenkel
Wijnanda J. Frenkel
BBBas van Den Bogaard
Bas van Den Bogaard
LBLizzy M. Brewster
Lizzy M. Brewster
LVLiffert Vogt
Liffert Vogt
BBBert-Jan H. van Den Born
Bert-Jan H. van Den Born
Thiazide diuretics are recommended as first-line therapy for hypertension and are among the most commonly prescribed drugs worldwide. According to their molecular structure, thiazide diuretics can be divided in thiazide-type (TT) and thiazide-like (TL) diuretics. TL diuretics have a longer elimination half-life compared with TT diuretics and have been shown to exert additional pharmacological effects, which may differently affect cardiovascular risk. In this meta-analysis, we compared the effects of TT and TL diuretics on cardiovascular events and mortality. Randomized, controlled studies in adult hypertensive patients that compared TT or TL diuretics with placebo or antihypertensive drugs and had ≥1 year follow-up were included. Primary outcome was cardiovascular events; secondary outcomes included coronary events, heart failure, cerebrovascular events, and all-cause mortality. Meta-regression analysis was used to identify confounders and correct for the achieved blood pressure reductions. Twenty-one studies with >480 000 patient-years were included. Outcomes were not affected by heterogeneity in age, sex, and ethnicity among included studies, whereas larger blood pressure reductions were significantly associated with increased risk reductions for all outcomes ( P <0.001). Corrected for differences in office blood pressure reductions among trials, TL diuretics resulted in a 12% additional risk reduction for cardiovascular events ( P =0.049) and a 21% additional risk reduction for heart failure ( P =0.023) when compared with TT diuretics. The incidence of adverse events was comparable among TT, TL diuretics, and other antihypertensive therapy. Our data suggest that the best available evidence seems to favor TL diuretics as the drug of choice when thiazide treatment is considered for hypertension.

1 April 2014 in Journal of Cardiothoracic and Vascular Anesthesia
Verified
Journal Article
Closed access
RERik Olde Engberink
Rik Olde Engberink
GKGerhardus J.A.J.M. Kuiper
Gerhardus J.A.J.M. Kuiper
RWRick J.H. Wetzels
Rick J.H. Wetzels
PNPatty J. Nelemans
Patty J. Nelemans
MLMarcus D. Lance
Marcus D. Lance
YHYvonne M.C. Henskens
Yvonne M.C. Henskens

5 September 2017 in Circulation
Verified
Journal Article
Closed access
PDF file
RERik Olde Engberink
Rik Olde Engberink
THThomas C. van Den Hoek
Thomas C. van Den Hoek
NNNicky D. van Noordenne
Nicky D. van Noordenne
BBBert-Jan H. van Den Born
Bert-Jan H. van Den Born
HPHessel Peters-Sengers
Hessel Peters-Sengers
LVLiffert Vogt
Liffert Vogt
Background: A decrease in sodium intake has been shown to lower blood pressure, but data from cohort studies on the association with cardiovascular and renal outcomes are inconsistent. In these studies, sodium intake was often estimated with a single baseline measurement, which may be inaccurate considering day-to-day changes in sodium intake and sodium excretion. We compared the effects of single versus repetitive follow-up 24-hour urine samples on the relation between sodium intake and long-term cardiorenal outcomes. Methods: We selected adult subjects with an estimated glomerular filtration rate >60 mL/min/1.73m 2 , an outpatient 24-hour urine sample between 1998 and 1999, and at least 1 collection during a 17-year follow-up. Sodium intake was estimated with a single baseline collection and the average of samples collected during a 1-, 5-, and 15-year follow-up. We used Cox regression analysis and the landmark approach to investigate the relation between sodium intake and cardiovascular (cardiovascular events or mortality) and renal (end-stage renal disease: dialysis, transplantation, and/or >60% estimated glomerular filtration rate decline, or mortality) outcomes. Results: We included 574 subjects with 9776 twenty-four–hour urine samples. Average age was 47 years, and 46% were male. Median follow-up was 16.2 years. Average 24-hour sodium excretion, ranging from 3.8 to 3.9 g (165–170 mmol), was equal among all methods ( P =0.88). However, relative to a single baseline measurement, 50% of the subjects had a >0.8-g (>34-mmol) difference in sodium intake with long-term estimations. As a result, 45%, 49%, and 50% of all subjects switched between tertiles of sodium intake when the 1-, 5-, or 15-year average was used, respectively. Consequently, hazard ratios for cardiorenal outcome changed up to 85% with the use of sodium intake estimations from short-term (1-year) and long-term (5-year) follow-up instead of baseline estimations. Conclusions: Relative to a single baseline 24-hour sodium measurement, the use of subsequent 24-hour urine samples resulted in different estimations of an individual’s sodium intake, whereas population averages remained similar. This finding had significant consequences for the association between sodium intake and long-term cardiovascular and renal outcomes.

1 July 2016 in The American Journal of Clinical Nutrition
Verified
Journal Article
Closed access
PDF file
ABAnna Birukov
Anna Birukov
NRNatalia Rakova
Natalia Rakova
KLKathrin Lerchl
Kathrin Lerchl
RERik Olde Engberink
Rik Olde Engberink
BJBernd Johannes
Bernd Johannes
JTJens Titze
Jens Titze
Background: The intake of sodium, chloride, and potassium is considered important to healthy nutrition and cardiovascular disease risk. Estimating the

1 April 2015 in Journal of the American Society of Nephrology
Verified
Journal Article
Closed access
RERik Olde Engberink
Rik Olde Engberink
NRNienke M.G. Rorije
Nienke M.G. Rorije
JHJaap J. Homan van der Heide
Jaap J. Homan van der Heide
BBBert-Jan H. van Den Born
Bert-Jan H. van Den Born
LVLiffert Vogt
Liffert Vogt
Excessive sodium intake is associated with both hypertension and an increased risk of cardiovascular events, presumably because of an increase in extracellular volume. The extent to which sodium intake affects extracellular volume and BP varies considerably among individuals, discriminating subjects who are salt-sensitive from those who are salt-resistant. Recent experiments have shown that, other than regulation by the kidney, sodium homeostasis is also regulated by negatively charged glycosaminoglycans in the skin interstitium, where sodium is bound to glycosaminoglycans without commensurate effects on extracellular volume. The endothelial surface layer is a dynamic layer on the luminal side of the endothelium that is in continuous exchange with flowing blood. Because negatively charged glycosaminoglycans are abundantly present in this layer, it may act as an intravascular buffer compartment that allows sodium to be transiently stored. This review focuses on the putative role of the endothelial surface layer as a contributor to salt sensitivity, the consequences of a perturbed endothelial surface layer on sodium homeostasis, and the endothelial surface layer as a possible target for the treatment of hypertension and an expanded extracellular volume.

26 October 2020 in Nutrients
Verified
Journal Article
Open access
PDF file
BGBigina Ginos
Bigina Ginos
RERik Olde Engberink
Rik Olde Engberink
Globally, average dietary sodium intake is double the recommended amount, whereas potassium is often consumed in suboptimal amounts. High sodium diets are associated with increased cardiovascular and renal disease risk, while potassium may have protective properties. Consequently, patients at risk of cardiovascular and renal disease are urged to follow these recommendations, but dietary adherence is often low due to high sodium and low potassium content in processed foods. Adequate monitoring of intake is essential to guide dietary advice in clinical practice and can be used to investigate the relationship between intake and health outcomes. Daily sodium and potassium intake is often estimated with 24-h sodium and potassium excretion, but long-term balance studies demonstrate that this method lacks accuracy on an individual level. Dietary assessment tools and spot urine collections also exhibit poor performance when estimating individual sodium and potassium intake. Collection of multiple consecutive 24-h urines increases accuracy, but also patient burden. In this narrative review, we discuss current approaches to estimating dietary sodium and potassium intake. Additionally, we explore alternative methods that may improve test accuracy without increasing burden.